100.72

0.04% 0.04

After Hours: 100.40 -0.32 -0.32%

Cvs Health Corp (CVS)

Overview News Price History Option Chain Financials Why CVS Down? Discussions Forecast Stock Split Dividend History

Cvs Health Corp stock is traded at $100.72, with a volume of 5.06M. It is up +0.04% in the last 24 hours and up +5.04% over the past month. CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

Previous Close:

$100.68

Open:

$100.725

24h Volume:

5.06M

Relative Volume:

0.63

Market Cap:

$128.51B

Revenue:

$407.94B

Net Income/Loss:

$2.90B

P/E Ratio:

44.23

EPS:

2.2771

Net Cash Flow:

$7.39B

1W Performance:

+3.77%

1M Performance:

+5.04%

6M Performance:

+28.65%

1Y Performance:

+48.75%

1-Day Range:

$98.75

$101.00

1-Week Range:

$96.13

$102.77

52-Week Range:

$58.50

$102.77

Cvs Health Corp Stock (CVS) Company Profile

Name

Cvs Health Corp

Sector

Healthcare (1107)

Industry

Healthcare Plans (11)

Phone

(401) 765-1500

Address

ONE CVS DR., WOONSOCKET

Employee

300,000

Twitter

@cvshealth

Next Earnings Date

2026-07-30

Latest SEC Filings

CVS's Discussions on Twitter

Compare CVS vs UNH, ELV, CI, HUM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CVS Cvs Health Corp	100.72	128.46B	407.94B	2.90B	7.39B	2.2771
UNH Unitedhealth Group Inc	407.65	373.28B	449.71B	12.81B	19.67B	13.24
ELV Elevance Health Inc	397.80	87.28B	200.42B	5.24B	6.45B	23.50
CI Cigna Group	291.88	77.73B	278.13B	6.74B	7.66B	23.60
HUM Humana Inc	369.49	45.65B	137.20B	1.15B	1.27B	9.3439

Cvs Health Corp Stock (CVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Upgrade	Bernstein	Mkt Perform → Outperform
Oct-14-25	Initiated	Goldman	Buy
Aug-18-25	Upgrade	UBS	Neutral → Buy
Aug-14-25	Upgrade	Robert W. Baird	Neutral → Outperform
Feb-13-25	Upgrade	Leerink Partners	Market Perform → Outperform
Feb-12-25	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jan-30-25	Upgrade	Edward Jones	Hold → Buy
Dec-03-24	Upgrade	Deutsche Bank	Hold → Buy
Nov-18-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-10-24	Upgrade	Barclays	Equal Weight → Overweight
Oct-04-24	Upgrade	TD Cowen	Hold → Buy
May-30-24	Initiated	Robert W. Baird	Neutral
May-07-24	Downgrade	TD Cowen	Buy → Hold
May-02-24	Downgrade	UBS	Buy → Neutral
May-01-24	Downgrade	Cantor Fitzgerald	Overweight → Neutral
May-01-24	Downgrade	Leerink Partners	Outperform → Market Perform
Mar-06-24	Initiated	Barclays	Equal Weight
Feb-26-24	Initiated	Leerink Partners	Outperform
Dec-22-23	Initiated	HSBC Securities	Buy
Sep-19-23	Upgrade	Evercore ISI	In-line → Outperform
Sep-12-23	Upgrade	Wolfe Research	Peer Perform → Outperform
Aug-18-23	Downgrade	Edward Jones	Buy → Hold
May-26-23	Initiated	Piper Sandler	Overweight
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line
Nov-23-22	Resumed	Morgan Stanley	Overweight
Jun-17-22	Initiated	Loop Capital	Buy
May-27-22	Downgrade	Bernstein	Outperform → Mkt Perform
Mar-29-22	Downgrade	Deutsche Bank	Buy → Hold
Feb-11-22	Downgrade	Raymond James	Strong Buy → Outperform
Dec-14-21	Initiated	Goldman	Buy
Dec-01-21	Initiated	Seaport Research Partners	Buy
May-19-21	Initiated	Wells Fargo	Equal Weight
Mar-17-21	Downgrade	Guggenheim	Buy → Neutral
Jan-08-21	Upgrade	Jefferies	Hold → Buy
Sep-17-20	Initiated	Piper Sandler	Overweight
Jul-01-20	Initiated	SVB Leerink	Mkt Perform
May-14-20	Upgrade	Credit Suisse	Neutral → Outperform
Sep-27-19	Resumed	RBC Capital Mkts	Outperform
Sep-12-19	Initiated	Deutsche Bank	Buy
Jun-05-19	Upgrade	Standpoint Research	Hold → Buy
Apr-29-19	Downgrade	Credit Suisse	Outperform → Neutral
Apr-18-19	Initiated	Guggenheim	Buy
Apr-15-19	Downgrade	Oppenheimer	Outperform → Perform
Apr-10-19	Reiterated	BofA/Merrill	Buy
Mar-13-19	Initiated	Bernstein	Outperform
Feb-20-19	Downgrade	Wells Fargo	Outperform → Market Perform
Jan-17-19	Initiated	UBS	Buy
Dec-18-18	Initiated	Barclays	Overweight
Nov-29-18	Resumed	Goldman	Neutral
Nov-28-18	Initiated	Evercore ISI	Outperform
Oct-26-18	Resumed	Wolfe Research	Peer Perform
Jul-09-18	Upgrade	Citigroup	Neutral → Buy
Feb-27-18	Resumed	BofA/Merrill	Buy
Feb-13-18	Reiterated	Citigroup	Neutral

View All

Cvs Health Corp Stock (CVS) Latest News

Jun 16, 2026

Focus Partners Wealth Buys 219,979 Shares of CVS Health Corporation $CVS - MarketBeat

Jun 16, 2026

Arax Advisory Partners Has $1.80 Million Stock Position in CVS Health Corporation $CVS - MarketBeat

Jun 16, 2026

Jun 15, 2026

Subscription push: CVS Health’s CarePass membership leans into everyday savings - AD HOC NEWS

Jun 15, 2026

CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch

Jun 15, 2026

1 Top Wall Street Analyst Thinks CVS Health Could Jump Another 13%. Should You Load Up on the Stock? - Yahoo Finance

Jun 15, 2026

1 Top Wall Street Analyst Thinks CVS Health Could Jump Another 13%. Should You Load Up on the Stock? - The Motley Fool

Jun 15, 2026

CVS Health Works To Steady Its Diversified Healthcare Model - Kalkine Media

Jun 15, 2026

Aetna Reduces Claims Processing Time by More Than 20% With AI To Improve Care Experience - marketscreener.com

Jun 15, 2026

CVS Health Corporation $CVS Shares Acquired by Resources Management Corp CT ADV - MarketBeat

Jun 15, 2026

Sachem Head Capital Management LP Decreases Stock Position in CVS Health Corporation $CVS - MarketBeat

Jun 15, 2026

Zacks.com featured highlights include StoneCo, USANA Health, Strategic Education, Nexa Resources and CVS - Yahoo Finance

Jun 15, 2026

CVS Pharmacy app: managing prescriptions and care from your phone - AD HOC NEWS

Jun 15, 2026

Arrowstreet Capital Limited Partnership Cuts Stake in CVS Health Corporation $CVS - MarketBeat

Jun 15, 2026

Why Is CVS Health Stock Trending Right Now - Kalkine Media

Jun 15, 2026

Is CVS Health (CVS) One of Billionaire Larry Robbins’ 10 Dividend Stock Picks? - Insider Monkey

Jun 15, 2026

Jun 14, 2026

HHS Scrutiny And Primary Care Expansion Shape CVS Health Investor Questions - Yahoo Finance Singapore

Jun 14, 2026

Epoch Investment Partners Inc. Has $166.25 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat

Jun 14, 2026

CVS Health Corporation $CVS Shares Bought by Adams Diversified Equity Fund Inc. - MarketBeat

Jun 14, 2026

Mizuho Raises CVS Health (CVS) Price Target on More Stable Policy Environment - Yahoo Finance

Jun 14, 2026

Jun 13, 2026

CVS Health Corp. Stock (US1266501006): Valuation Back In Focus After Recent Rebound - AD HOC NEWS

Jun 13, 2026

State Street Corp Acquires 1,245,457 Shares of CVS Health Corporation $CVS - MarketBeat

Jun 13, 2026

CVS Health Corporation $CVS Shares Acquired by Rhenman & Partners Asset Management AB - MarketBeat

Jun 13, 2026

Macquarie Group Ltd. Lowers Stock Position in CVS Health Corporation $CVS - MarketBeat

Jun 13, 2026

CVS Health (NYSE:CVS) Stock Rating Lowered by Wall Street Zen - MarketBeat

Jun 13, 2026

Jun 12, 2026

CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch

Jun 12, 2026

Is CVS (CVS) Using GLP-1 Access and AI Tools to Redefine Its Healthcare Moat? - Yahoo Finance

Jun 12, 2026

Danaher Boosts Product Portfolio With the Acquisition of Masimo - TradingView

Jun 12, 2026